首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   1612篇
  免费   58篇
  国内免费   32篇
  1702篇
  2023年   20篇
  2022年   14篇
  2021年   18篇
  2020年   20篇
  2019年   46篇
  2018年   40篇
  2017年   33篇
  2016年   33篇
  2015年   34篇
  2014年   118篇
  2013年   120篇
  2012年   75篇
  2011年   102篇
  2010年   74篇
  2009年   79篇
  2008年   80篇
  2007年   94篇
  2006年   77篇
  2005年   64篇
  2004年   47篇
  2003年   40篇
  2002年   49篇
  2001年   35篇
  2000年   31篇
  1999年   27篇
  1998年   23篇
  1997年   26篇
  1996年   15篇
  1995年   15篇
  1994年   16篇
  1993年   16篇
  1992年   20篇
  1991年   12篇
  1990年   11篇
  1989年   23篇
  1988年   8篇
  1987年   15篇
  1986年   8篇
  1985年   13篇
  1984年   8篇
  1983年   10篇
  1982年   7篇
  1981年   12篇
  1980年   8篇
  1979年   6篇
  1975年   8篇
  1974年   5篇
  1973年   9篇
  1972年   15篇
  1971年   15篇
排序方式: 共有1702条查询结果,搜索用时 15 毫秒
21.
Jeffries et al. (2018) investigated testing for a treatment difference in the setting of a randomized clinical trial with a single outcome measured longitudinally over a series of common follow-up times while adjusting for covariates. That paper examined the null hypothesis of no difference at any follow-up time versus the alternative of a difference for at least one follow-up time. We extend those results here by considering multivariate outcome measurements, where each individual outcome is examined at common follow-up times. We consider the case where there is interest in first testing for a treatment difference in a global function of the outcomes (e.g., weighted average or sum) with subsequent interest in examining the individual outcomes, should the global function show a treatment difference. Testing is conducted for each follow-up time and may be performed in the setting of a group sequential trial. Testing procedures are developed to determine follow-up times for which a global treatment difference exists and which individual combinations of outcome and follow-up time show evidence of a difference while controlling for multiplicity in outcomes, follow-up, and interim analyses. These approaches are examined in a study evaluating the effects of tissue plasminogen activator on longitudinally obtained stroke severity measurements.  相似文献   
22.
目的 :评估新型转染试剂Vigofect介导gfp - 2mar基因转染BHK细胞的转染效率及其对细胞的毒性作用 ,并与传统转染试剂LipofectAMINE进行比较。方法 :将适量的gfp - 2mar分别用等量的LipofectAMINE和Vigofect转染BHK细胞 ,于转染后 4 8h用MTT比色法检测活细胞数 ,以GFP为报告基因 ,在荧光显微镜下观察并用流式细胞仪计数荧光细胞 ,检测转染效率。结果 :Lipo fectAMINE转染组细胞存活率为 96 .5 1± 3.12 % ,显著大于Vigofect转染组 6 1.4 3± 16 .89% (P <0 .0 1) ;Vigofect转染效率为 5 9.2±19 .5 1% ,显著高于LipofectAMINE 10 .72± 8.17% (P <0 .0 2 )。结论 :与LipofectAMINE相比较 ,Vigofect对细胞毒性较大 ,但转染效率较高  相似文献   
23.
In order to find novel antitumor candidate agents with high efficiency and low toxicity, 14 novel substituted 5‐anilino‐α‐glucofuranose derivatives have been designed, synthesized and evaluated for antiproliferative activities in vitro. Their structures were characterized by NMR (1H and 13C) and HR‐MS, and configuration (R/S) at C(5) was identified by two‐dimensional 1H,1H‐NOESY‐NMR spectrum. Their antiproliferative activities against human tumor cells were investigated by MTT assay. The results demonstrated that most of the synthesized compounds had antiproliferative effects comparable to the reference drugs gefitinib and lapatinib. In particular, (5R)‐5‐O‐(3‐chloro‐4‐{[5‐(4‐fluorophenyl)thiophen‐2‐yl]methyl}anilino)‐5‐deoxy‐1,2‐O‐(1‐methylethylidene)‐α‐glucofuranose ( 9da ) showed the most potent antiproliferative effects against SW480, A431 and A549 cells, with IC50 values of 8.57, 5.15 and 15.24 μm , respectively. This work suggested 5‐anilino‐α‐glucofuranose as an antitumor core structure that may open a new way to develop more potent anti‐cancer agents.  相似文献   
24.
Breeding to increase crop resistance is a common strategy to decrease damage caused by insect pests, especially in the current context where insecticides are becoming at the same time less accepted by society and less efficient because of widespread pest resistance. The main bottleneck of this strategy is phenotyping. Although simple, high‐throughput methods have been proposed which could be highly useful, they may raise conceptual issues. Using field and laboratory experiments on oilseed rape (Brassica napus) and the pollen beetle (Brassicogethes aeneus syn. Meligethes aeneus), we illustrated possible difficulties with this approach: (i) field screenings might not represent the real attractiveness of the tested genotypes; (ii) plant phenology or spatial organization of the genotypes might bias field screening results; (iii) experiments based on detached plant parts (here, single flower buds or anthers) might not allow to infer the plant–insect relationship of the whole plant. We propose ways to better take these risks into account.  相似文献   
25.
In this study, tri‐functional immunofluorescent probes (Ce6–IgG–QDs) based on covalent combinations of quantum dots (QDs), immunoglobulin G (IgG) and chlorin e6 (Ce6) were developed and their photodynamic ability to induce the death of cancer cells was demonstrated. Strategically, one type of second‐generation photosensitizer, Ce6, was first coupled with anti‐IgG antibody using the EDC/NHS cross‐linking method to construct the photosensitive immunoconjugate Ce6–IgG. Then, a complex of Ce6–IgG–QDs immunofluorescent probes was obtained in succession by covalently coupling Ce6–IgG to water soluble CdTe QDs. The as‐manufactured Ce6–IgG–QDs maintained the bio‐activities of both the antigen–antibody‐based tumour targeting effects of IgG and the photodynamic‐related anticancer activities of Ce6. By way of polyclonal antibody interaction with rabbit anti‐human epidermal growth factor receptor (anti‐EGFR antibody, N‐terminus), Ce6–IgG–QDs were labelled indirectly onto the surface of human hepatocarcinoma (HepG2) cells in cell recognition and killing experiments. The results indicated that the Ce6–IgG–QDs probes have excellent tumour cell selectivity and higher photosensitivity in photodynamic therapy (PDT) compared with Ce6 alone, due to their antibody‐based specific recognition and location of HepG2 cells and the photodynamic effects of Ce6 killed cells based on efficient fluorescence resonance energy transfer between QDs and Ce6. Copyright © 2015 John Wiley & Sons, Ltd.  相似文献   
26.
本文根据MTT只能被活的增殖细胞中线粒体切断形成紫色甲(?)的原理,测定了8—甲氧基补骨脂素(8—MOP)对体外培养人癌细胞系HCT、KB和BEL细胞的光敏灭活作用。结果表明,8—MOP和UVA光照对这几种人癌细胞有肯定的灭活作用,该作用与8—MOP剂量和光照时间以及细胞种类有关;MTT法可以作为光敏剂活性检测的一种快捷方法。  相似文献   
27.
MTT方法评价微生物细胞活性的探讨   总被引:4,自引:0,他引:4  
对MTT比色法用于评价微生物细胞活性进行了探讨。本文以大肠杆菌为模式菌株,研究了不同浓度MTT、不同用量、在不同时间对试验结果OD570值的影响,结果表明细菌数在4.9×107-4.9×108个/mL范围内测出的OD570值与细菌浓度呈良好的正相关,0.5 mg/mL MTT用量20 &#61549;L,反应时间20 min时效果最佳,其相关回归方程为y = 0.1769x + 0.03,R2 = 0.9983。  相似文献   
28.
为研究氟代柠檬酸(Fluorocitrate)对体外培养的神经胶质瘤细胞生长的影响,采用MTT法研究不同的氟代柠檬酸浓度(0.0025mmol/L,0.005mmol/L,0.01 mmol/L,0.025mmol/L和0.1 mmol/L)和作用时间(36h,48h和60h)对神经胶质瘤细胞G422增殖的影响.结果发现:(1)氟代柠檬酸可抑制G422细胞的增殖,并且其抑制作用随氟代柠檬睃浓度的增加而增强;(2)高浓度(0.01 mmol/L,0.025 mmol/L和0.1 mmol/L)氟代柠檬酸对G422细胞的增殖抑制作用随作用时问的延长而增强:(3)低浓度(0.0025mmol/L和0.005mmol/L)氟代柠檬酸对G422细胞的增殖抑制作用不随作用时间的延长而改变.实验表明,氟代柠檬酸能够抑制神经胶质瘤细胞的增殖,其抑制能力随氟代柠檬酸浓度的增加和作用时间的延长而加强.  相似文献   
29.
一株斜纹夜蛾核型多角体病毒毒力及基因组酶切的研究王晓容,刘明富,刘润忠,兰萍章,张友清(中国科学院武汉病毒研究所,武汉430071)关键词斜纹夜蛾,核多角体病毒,毒力测定,限制酶分析斜纹夜蛾(Spodopleralitura)是重要的农业害虫之一。关...  相似文献   
30.
Despite improved treatment options, glioblastoma multiforme (GBM) remains the most aggressive brain tumour with the shortest post-diagnostic survival. Arsenite (As2O3) is already being used in the treatment of acute promyelocytic leukaemia (APL), yet its effects on GBM have not been evaluated in detail. In U87MG cell monolayers, we have previously shown that arsenite cytotoxicity significantly increases upon transient inhibition of lysosomal protease Cathepsin L (CatL). As multicellular spheroids more closely represent in vivo tumours, we aimed to evaluate the impact of permanent CatL silencing on arsenite treatment in U87MG spheroids. CatL was stably silenced using shRNA expression plasmid packed lentiviruses. By using metabolic- and cell viability assays, we demonstrated that long-term CatL silencing significantly increased arsenite cytotoxicity in U87MG spheroids. Silenced CatL also increased arsenite-mediated apoptosis in spheroids via elevated p53 expression, Bax/Bcl2 ratio and caspase 3/7 activity, though with lower efficacy than in monolayers. Arsenite cytotoxicity was enhanced by lower CatL activity, since similar cytotoxicity increase was also observed using the novel CatL inhibitor AT094. The results have significant translational impact, since stable CatL silencing would enable the application of lower systemic doses of arsenite to achieve the desired cytotoxic effects on GBMs in vivo.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号